226 related articles for article (PubMed ID: 28277784)
21.
Wang YC; Wu MT; Tang FY; Chen DY; Ko HA; Shane B; Huang WN; Chiang EP
Clin Sci (Lond); 2019 Jan; 133(2):253-267. PubMed ID: 30606816
[No Abstract] [Full Text] [Related]
22. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
[TBL] [Abstract][Full Text] [Related]
23. Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients.
Chaabane S; Messedi M; Akrout R; Ben Hamad M; Turki M; Marzouk S; Keskes L; Bahloul Z; Rebai A; Ayedi F; Maalej A
Inflamm Res; 2018 Aug; 67(8):703-710. PubMed ID: 29796841
[TBL] [Abstract][Full Text] [Related]
24. MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms.
Owen SA; Lunt M; Bowes J; Hider SL; Bruce IN; Thomson W; Barton A
Pharmacogenomics J; 2013 Apr; 13(2):137-47. PubMed ID: 21931346
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of MTHFR polymorphism screening by polymerase chain reaction in Korean patients with rheumatoid arthritis receiving methotrexate.
Kim SK; Jun JB; El-Sohemy A; Bae SC
J Rheumatol; 2006 Jul; 33(7):1266-74. PubMed ID: 16758511
[TBL] [Abstract][Full Text] [Related]
26. Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis.
Hughes LB; Beasley TM; Patel H; Tiwari HK; Morgan SL; Baggott JE; Saag KG; McNicholl J; Moreland LW; Alarcón GS; Bridges SL
Ann Rheum Dis; 2006 Sep; 65(9):1213-8. PubMed ID: 16439441
[TBL] [Abstract][Full Text] [Related]
27. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients.
van Ede AE; Laan RF; Blom HJ; Huizinga TW; Haagsma CJ; Giesendorf BA; de Boo TM; van de Putte LB
Arthritis Rheum; 2001 Nov; 44(11):2525-30. PubMed ID: 11710708
[TBL] [Abstract][Full Text] [Related]
28. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.
Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P
Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563
[TBL] [Abstract][Full Text] [Related]
29. Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.
Davis LA; Polk B; Mann A; Wolff RK; Kerr GS; Reimold AM; Cannon GW; Mikuls TR; Caplan L
Clin Exp Rheumatol; 2014; 32(3):324-32. PubMed ID: 24447348
[TBL] [Abstract][Full Text] [Related]
30. MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C Polymorphisms and Disease Activity in Mexicans with Rheumatoid Arthritis Treated with Methotrexate.
González-Mercado MG; Rivas F; Gallegos-Arreola MP; Morán-Moguel MC; Salazar-Páramo M; González-López L; Gámez-Nava JI; Muñoz-Valle JF; Medina-Coss Y León R; González-Mercado A; Aceves MA; Dávalos NO; Macías-Chumacera A; Dávalos IP
Genet Test Mol Biomarkers; 2017 Nov; 21(11):698-704. PubMed ID: 28994615
[TBL] [Abstract][Full Text] [Related]
31. Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis.
Spyridopoulou KP; Dimou NL; Hamodrakas SJ; Bagos PG
Pharmacogenet Genomics; 2012 Feb; 22(2):117-33. PubMed ID: 22143415
[TBL] [Abstract][Full Text] [Related]
32. Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis.
Cen H; Huang H; Zhang LN; Liu LY; Zhou L; Xin XF; Zhuo RJ
Clin Rheumatol; 2017 Feb; 36(2):287-297. PubMed ID: 27423206
[TBL] [Abstract][Full Text] [Related]
33. MTHFR gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis based on 16 studies.
Bagheri-Hosseinabadi Z; Imani D; Yousefi H; Abbasifard M
Clin Rheumatol; 2020 Aug; 39(8):2267-2279. PubMed ID: 32170488
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.
Davis LA; Cannon GW; Pointer LF; Haverhals LM; Wolff RK; Mikuls TR; Reimold AM; Kerr GS; Richards JS; Johnson DS; Valuck R; Prochazka A; Caplan L
J Rheumatol; 2013 Jun; 40(6):809-17. PubMed ID: 23547211
[TBL] [Abstract][Full Text] [Related]
35. MTHFR functional genetic variation and methotrexate treatment response in rheumatoid arthritis: a meta-analysis.
Morgan MD; Al-Shaarawy N; Martin S; Robinson JI; Twigg S; ; Magdy AA; Omar AS; Ghattas MH; Emery P; Barrett JH; Morgan AW
Pharmacogenomics; 2014 Mar; 15(4):467-75. PubMed ID: 24624914
[TBL] [Abstract][Full Text] [Related]
36. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
Kurzawski M; Pawlik A; Safranow K; Herczynska M; Drozdzik M
Pharmacogenomics; 2007 Nov; 8(11):1551-9. PubMed ID: 18034620
[TBL] [Abstract][Full Text] [Related]
37. 677TT genotype is associated with elevated risk of methotrexate (MTX) toxicity in juvenile idiopathic arthritis: treatment outcome, erythrocyte concentrations of MTX and folates, and MTHFR polymorphisms.
Tuková J; Chládek J; Hroch M; Nemcová D; Hoza J; Dolezalová P
J Rheumatol; 2010 Oct; 37(10):2180-6. PubMed ID: 20595278
[TBL] [Abstract][Full Text] [Related]
38. Short Communication: Lack of association between MTHFR gene polymorphisms and response to methotrexate treatment in Pakistani patients with rheumatoid arthritis.
Iqbal MP; Ali AA; Mehboobali N; Iqbal K
Pak J Pharm Sci; 2015 Sep; 28(5):1789-92. PubMed ID: 26408898
[TBL] [Abstract][Full Text] [Related]
39. Methotrexate: Implications of pharmacogenetics in the treatment of patients with Rheumatoid Arthritis.
Torres RP; Santos FP; Branco JC
ARP Rheumatol; 2022 Oct; 1(3):225-229. PubMed ID: 35724450
[TBL] [Abstract][Full Text] [Related]
40. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.
Lima A; Monteiro J; Bernardes M; Sousa H; Azevedo R; Seabra V; Medeiros R
Biomed Res Int; 2014; 2014():368681. PubMed ID: 24967362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
